Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Cannabotech ( (IL:CNTC) ) is now available.
Cannabotech has appointed Nikita Lelyukh as a regular director, effective February 10, 2025. Lelyukh, who has experience as a marketing company owner and founding partner in a startup investment company, does not hold any securities in the company nor serves on its board committees. The appointment reflects Cannabotech’s strategic move to integrate skilled individuals with diverse backgrounds into its leadership team, potentially enhancing its market positioning and operational effectiveness.
More about Cannabotech
Cannabotech operates in the biotechnology industry, focusing on developing and commercializing botanical-based healthcare products. The company is listed on the Tel Aviv Stock Exchange, emphasizing its role in innovative health solutions.
YTD Price Performance: -26.42%
Average Trading Volume: 11,328
See more insights into CNTC stock on TipRanks’ Stock Analysis page.